Successful use of the APTT in monitoring of the anti-factor Xa activity of the heparinoid organon 10172 in a case of HITS requiring open heart surgery.
Marshall
L R
LR
Cannell
P K
PK
Herrmann
R P
RP
D000911:Antibodies, Monoclonal / Q000097:blood*; D000925:Anticoagulants / Q000276:immunology*; D002809:Chondroitin Sulfates; D001026:Coronary Artery Bypass; D003871:Dermatan Sulfate; D015951:Factor Xa / Q000276:immunology*; D006025:Glycosaminoglycans / Q000276:immunology* / Q000627:therapeutic use; D006493:Heparin / Q000009:adverse effects*; D006497:Heparan Sulfate; D006801:Humans; D008991:Monitoring, Physiologic / Q000379:methods; D010314:Partial Thromboplastin Time; D013921:Thrombocytopenia / Q000276:immunology*
D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D015951:Factor Xa; D006025:Glycosaminoglycans; D006493:Heparin; D006497:Heparan Sulfate; C035838:danaparoid